Common acute lymphoblastic leukemia in a girl with genetically confirmed LEOPARD syndrome

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 8, 2008, Pages 602-604

  Laux, Daniela ^a   Kratz, Christian ^b   Sauerbrey, Axel ^a  

^a HELIOS KLINIKUM ERFURT   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Common acute lymphoblastic leukemia (c ALL); LEOPARD syndrome; Noonan syndrome; PTPN11

Indexed keywords

MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; ANTINEOPLASTIC AGENT; PTPN11 PROTEIN, HUMAN;

ABDOMINAL ABSCESS; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; CHILD; DRUG DOSE REDUCTION; EXON; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; LEOPARD SYNDROME; LEUKEMOGENESIS; MAINTENANCE THERAPY; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; GENETICS; LYMPHATIC LEUKEMIA; MISSENSE MUTATION; PATHOPHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CHILD; FEMALE; HUMANS; LEOPARD SYNDROME; MUTATION, MISSENSE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11;

EID: 53749095511     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31817588fb     Document Type: Article

References (25)

1. Gorlin RJ, Anderson RC, Blaw M. Multiple lentigenes syndrome. Am J Dis Child. 1969;117:652-662.
2. Voron DA, Hatfield HH, Kalkhoff RK. Multiple lentigines syndrome. Case report and review of the literature. Am JMed. 1976; 60:447-456.
3. Digilio MC, Sarkozy A, de Zorzi A, et al. LEOPARD syndrome: clinical diagnosis in the first year of life. Am J Med Genet. 2006;140: 740-746.
4. Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet.2005;6:45-68.
5. Pandit B, Sarkozy A, Pennacchio LA, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007;39:1007-1012. Epub July 1, 2007.
6. Tartaglia M, Martinelli S, Stella L, et al. Diversity and functional consequences of Germline and Somatic PTPN11 mutations in human disease. Am J Hum Genet. 2006;78:279-290.
7. Digilio MC, Conti E, Sarkozy A, et al. Grouping of multiplelentigines/ LEOPARD and Noonan syndromes on the PTPN11gene. Am J Hum Genet. 2002;71:389-394.
8. Kontaridis MI, Swanson KD, David FS, et al. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J Biol Chem. 2006;281:6785-6792.
9. Loh ML, Vattikuti S, Schubbert S, et al. Mutations in PTPN11implicate the SHP-2 phosphatase in leukemogenesis. Blood.2004;103:2325-2331.
10. Tartaglia M, Martinelli S, Cazzaniga G, et al. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood. 2004;104:307-313.
11. Yamamoto T, Isomura M, Xu Y, et al. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia. Leuk Res.2006;30:1085-1089.
12. Kratz CP, Niemeyer CM, Castleberry RP, et al. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood. 2005;106: 2183-2185. Epub May 31, 2005.
13. Piombo M, Rosanda C, Pasino M, et al. Acute lymphoblastic leukemia in Noonan syndrome: report of two cases. Med Pediatr Oncol. 1993;21:454-455.
14. Roti G, La Starza R, Ballanti S, et al. Acute lymphoblastic leukaemia in Noonan syndrome. Br J Haematol. 2006;133:448-450.
15. Ucar C, Calyskan U, Martini S, et al. Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive). J Pediatr Hematol Oncol. 2006;28:123-125.
16. Keren B, Hadchouel A, Saba S, et al. PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience.JMed Genet. 2004;41:e117.
17. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALLBFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia. 2000;14:2205-2022.
18. Karow A, Steinemann D, Gohring G, et al. Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome. Leukemia. 2007;21:1303-1305. Epub March 15, 2007.
19. Chantrain CF, Jijon P, De Raedt T, et al. Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation. Pediatr Blood Cancer. 2007;48:101-104.
20. Kratz CP, Niemeyer CM, Zenker M. An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med. 2007;85:223-231.
21. Gelb BD, Tartaglia M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum Mol Genet. 2006;15 Spec No 2:R220-R226. Review.
22. Fukuda M, Horibe K, Miyajima Y, et al. Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome. J Pediatr Hematol Oncol. 1997;19:177-179.
23. Choong K, Freedman MH, Chitayat D, et al. Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol.1999;21:523-527. Review.
24. Mohi MG, Williams IR, Dearolf CR, et al. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell. 2005;7:179-191.
25. Schubbert S, Lieuw K, Rowe SL, et al. Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood. 2005;106:311-317. Epub March 10, 2005.